Department of Microbiology, Awanui Laboratories Wellington, Wellington, New Zealand.
Department of Infection Services, Te Whatu Ora/Health NZ-Capital, Coast and Hutt Valley, Wellington, New Zealand.
J Clin Microbiol. 2024 Jun 12;62(6):e0034224. doi: 10.1128/jcm.00342-24. Epub 2024 May 24.
A prior analysis suggested that wound swab culture (WSC) results were driving unnecessary antibiotic use in patients who were not already receiving treatment. As a quality-improvement initiative, our laboratory introduced an "exception-reporting" protocol on 1 March 2023, whereby typical wound pathogens susceptible to recommended empiric therapy (flucloxacillin/cefalexin) were not reported, and a comment was provided, stating no significant resistant organisms had been detected. Full results were available to clinicians on request. Cultures falling outside protocol criteria were reported in the standard fashion. This analysis sought to assess the effect of exception-reporting on post-report antibiotic initiation (PRAI). All community WSC results were matched to antibiotic dispensing records from October 2021 to December 2023. Sampling without treatment pre-report was termed "test and wait" (TaW). Following TaW, PRAI was identified if antibiotics were started within 5 days post-report. There were 1,819 and 764 WSCs received in the pre-change and post-change periods, respectively, where an initial TaW approach had been taken and an organism eligible for exception-reporting had been isolated. In the post-change period, 407 (53.3%) met the criteria and were exception-reported. PRAI occurred in 901 (49.5%) pre-change samples, compared to 102 (25.1%, < 0.01) with exception-reporting. There was no detectable increase in hospitalization or repeat WSC collection in the 30 days following exception-reporting. Exception-reporting was associated with a markedly reduced proportion of patients being initiated on antibiotics following WSC where an organism had been isolated. The naming of organisms in reports appears to drive unnecessary antibiotic prescribing in many patients. These results require confirmation in other jurisdictions.
Wound swab culture is a high-volume test performed in clinical microbiology laboratories. In this analysis, we have shown that an alternative approach to reporting positive wound swab cultures has resulted in a large reduction in post-report antibiotic initiation, suggesting that the current standard method of reporting generates considerable unnecessary antibiotic use. If these findings are replicated elsewhere, wider adoption of this reporting would represent an opportunity for many clinical microbiology laboratories to have a significant impact on community antimicrobial stewardship.
先前的分析表明,伤口拭子培养(WSC)结果导致已经接受治疗的患者不必要地使用抗生素。作为一项质量改进措施,我们的实验室于 2023 年 3 月 1 日引入了一项“异常报告”协议,即对推荐经验性治疗(氟氯西林/头孢氨苄)敏感的典型伤口病原体不进行报告,并提供评论,指出未检测到有意义的耐药生物。临床医生可根据要求获得完整的结果。不符合协议标准的培养物按标准方式报告。本分析旨在评估异常报告对报告后抗生素起始(PRAI)的影响。所有社区 WSC 结果都与 2021 年 10 月至 2023 年 12 月的抗生素配药记录相匹配。报告前未经治疗的采样称为“测试和等待”(TaW)。在 TaW 之后,如果在报告后 5 天内开始使用抗生素,则确定 PRAI。在改变前和改变后期间,分别接受了 1819 次和 764 次 WSC 检测,其中采用了初始 TaW 方法,并分离出适合异常报告的生物体。在改变后期间,符合标准的有 407 例(53.3%)被异常报告。在改变前样本中,901 例(49.5%)发生 PRAI,而异常报告的 102 例(25.1%,<0.01)。在异常报告后 30 天内,没有检测到住院或重复 WSC 采集的增加。WSC 分离出生物体后,异常报告与患者使用抗生素的比例明显降低有关。报告中生物体的命名似乎导致许多患者不必要地开抗生素。这些结果需要在其他司法管辖区得到证实。
伤口拭子培养是临床微生物学实验室进行的一项高容量检测。在本分析中,我们表明,报告阳性伤口拭子培养的替代方法导致报告后抗生素起始的大幅减少,这表明当前的标准报告方法会产生大量不必要的抗生素使用。如果这些发现得到其他地方的复制,更广泛地采用这种报告将为许多临床微生物学实验室提供一个机会,对社区抗菌药物管理产生重大影响。